Rifabutin‐based ‘rescue therapy’ for Helicobacter pylori infected patients after failure of standard regimens
Open Access
- 1 March 2000
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (3) , 311-316
- https://doi.org/10.1046/j.1365-2036.2000.00719.x
Abstract
Background: The ideal treatment for patients who have failed eradication of Helicobacter pylori infection after standard proton pump inhibitor‐based triple therapies has still to be determined. Alth...Keywords
This publication has 21 references indexed in Scilit:
- Treatment options for Helicobacter pylori infection when proton pump inhibitor‐based triple therapy fails in clinical practiceAlimentary Pharmacology & Therapeutics, 1999
- An increase in antibiotic-resistant Helicobacter pylori strains after new triple therapyGastroenterology, 1998
- What Other Regimens Are Under Investigation to Treat Helicobacter pylori Infection?Gastroenterology, 1997
- One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori : differing efficacy in previously treated and untreated patientsAlimentary Pharmacology & Therapeutics, 1996
- Antimicrobial Activity of RifabutinClinical Infectious Diseases, 1996
- Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitroJournal of Antimicrobial Chemotherapy, 1996
- Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre studyEuropean Journal of Gastroenterology & Hepatology, 1995
- Hitting H pylori for fourThe Lancet, 1995
- RifabutinDrugs, 1994
- Cresyl fast violet staining method for Campylobacter like organisms.Journal of Clinical Pathology, 1987